What is a stock summary page? Click here for an overview.
Business Description
Dechra Pharmaceuticals PLC
ISIN : GB0009633180
Share Class Description:
DCHPF: Ordinary SharesDescription
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 0.86 | |||||
| 12-1 Month Momentum % | 44.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.33 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 5-Year Yield-on-Cost % | 0.33 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 4.27 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | 49.47 | |||||
| EV-to-Forward-Revenue | 5.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DCHPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dechra Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 944.658 | ||
| EPS (TTM) ($) | -0.321 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.29 | ||
| Volatility % | 55.58 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | 44.75 | ||
| 52-Week Range ($) | 30 - 47.4 | ||
| Shares Outstanding (Mil) | 113.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dechra Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dechra Pharmaceuticals PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dechra Pharmaceuticals PLC Frequently Asked Questions
What is Dechra Pharmaceuticals PLC(DCHPF)'s stock price today?
The current price of DCHPF is $46.90. The 52 week high of DCHPF is $47.40 and 52 week low is $30.00.
When is next earnings date of Dechra Pharmaceuticals PLC(DCHPF)?
The next earnings date of Dechra Pharmaceuticals PLC(DCHPF) is 2025-10-11 Est..
Does Dechra Pharmaceuticals PLC(DCHPF) pay dividends? If so, how much?
The Dividend Yield %  of Dechra Pharmaceuticals PLC(DCHPF) is 0.33% (As of Today), Highest Dividend Payout Ratio of Dechra Pharmaceuticals PLC(DCHPF) was 0.48. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Dechra Pharmaceuticals PLC(DCHPF) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers